Back
Denali Therapeutics Stock Price Chart
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
DNLI
Denali Therapeutics
Last Price:
$14.81
Seasonality Move:
12.15%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.44 | Buy |
| 20-day SMA: | 15.17 | Sell |
| 50-day SMA: | 19.15 | Sell |
| 200-day SMA: | 23.23 | Sell |
| 8-day EMA: | 11.9 | Buy |
| 20-day EMA: | 7.24 | Buy |
| 50-day EMA: | 3.51 | Buy |
| 200-day EMA: | 0.97 | Buy |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 39.87 | Sell |
| Chaikin Money Flow: | 1292054 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.04 - 18.16) | Sell |
| Bollinger Bands (100): | (17.51 - 25.85) | Sell |
Denali Therapeutics Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
-
Denali Therapeutics share price is 14.78 while DNLI 8-day simple moving average is 14.44, which is a Buy signal.
-
The stock price of DNLI is 14.78 while Denali Therapeutics 20-day SMA is 15.17, which makes it a Sell.
-
Denali Therapeutics 50-day simple moving average is 19.15 while DNLI share price is 14.78, making it a Sell technically.
-
DNLI stock price is 14.78 and Denali Therapeutics 200-day simple moving average is 23.23, creating a Sell signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
19
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a SellThe current Denali Therapeutics [DNLI] share price is $14.78. The Score for DNLI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics Stock Info
Market Cap:
2.1B
Price in USD:
14.78
Share Volume:
1.5M
Denali Therapeutics 52-Week Range
52-Week High:
33.33
52-Week Low:
13.67
Sell
19
Denali Therapeutics (DNLI)
is a Sell
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?The Denali Therapeutics stock price is 14.78 USD today.
-
Will DNLI stock go up or go down?Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Denali Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is overvalued.
Is Denali Therapeutics Stock a Buy?
-
Denali Therapeutics share price is 14.78 while DNLI 8-day exponential moving average is 11.90, which is a Buy signal.
-
The stock price of DNLI is 14.78 while Denali Therapeutics 20-day EMA is 7.24, which makes it a Buy.
-
Denali Therapeutics 50-day exponential moving average is 3.51 while DNLI share price is 14.78, making it a Buy technically.
-
DNLI stock price is 14.78 and Denali Therapeutics 200-day simple moving average is 0.97, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.25 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
-
DNLI Moving Average Covergence Divergence (MACD) indicator is 3.92, suggesting Denali Therapeutics is a Buy
-
Denali Therapeutics Relative Strength Index (RSI) is 39.87, which suggest Denali Therapeutics is oversold
-
The Bollinger Bands (25) for Denali Therapeutics is (14.04 - 18.16), which suggest Denali Therapeutics is a Sell
-
The Bollinger Bands (100) for Denali Therapeutics is (17.51 - 25.85), which suggest Denali Therapeutics is a Sell
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.